Not cancer · Austria
Coronary artery disease
How is it diagnosed today? Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. MedlinePlus
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.26 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Lifestyle changes and medicines; stents or bypass if needed. NHS
15 medicines are approved for this disease in Austria:
Show all 15
- Cangrelor (Kengrexal) – approved in 2015
- Clopidogrel (Clopidogrel Zentiva, Plavix, Clopidogrel Viatris) – approved in 1998
- Clopidogrel and acetylsalicylic acid (DuoPlavin, Clopidogrel / Acetylsalicylic acid Viatris, Clopidogrel/Acetylsalicylic acid Zentiva) – approved in 2010
- Colchicine (Colchicine Agepha Pharma, Colctab) – approved in 2026
- Enoxaparin (Inhixa, Lovenox, Enoxaparin sodium) – approved in 2016
- Eptifibatide (Eptifibatide Accord, Eptifibatide) – approved in 2016
- Evolocumab (Repatha) – approved in 2015
- Fondaparinux (Arixtra) – approved in 2002
- Ivabradine (Ivabradine Anpharm, Corlentor, Procoralan) – approved in 2005
- Prasugrel (Prasugrel Viatris, Efient, Effient) – approved in 2009
- Ranolazine (Ranexa, Aspruzyo Sprinkle) – approved in 2008
- Rivaroxaban (Rivaroxaban Viatris, Xarelto, Rivaroxaban Accord) – approved in 2008
- Telmisartan (Micardis, Tolura, Telmisartan Actavis) – approved in 1998
- Tenecteplase (Metalyse, TNKase) – approved in 2001
- Ticagrelor (Brilique, Brilinta, Ticagrelor Zydus) – approved in 2010
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (56)
- Acebutolol (Sectral, Acebutolol Teva) – approved for it in France
- Acenocoumarol (Sintrom) – approved for it in France
- Acetylsalicylic acid (Aspirin Cardio) – approved for it in Switzerland
- Alirocumab (Praluent) – approved for it in the US
- Alteplase (Activase, Actilyse) – approved for it in the US, Switzerland, and France
- Amlodipine (Norliqva, Sdamlo, Amlodipine Besylate) – approved for it in the US and France
- Amlodipine and atorvastatin (Caduet) – approved for it in the US
- Atenolol (Tenormin, Tenormine, Atenolol Biogaran) – approved for it in the US and France
- Atorvastatin (Atorvaliq, Atorvastatin Calcium) – approved for it in the US
- Atorvastatin and ezetimibe (Ezetimibe/Atorvastatine Biogaran) – approved for it in France
- Bempedoic acid (Nexletol) – approved for it in the US
- Bempedoic acid and ezetimibe (Nexlizet) – approved for it in the US
- Betaxolol (Kerlone, Betaxolol Eg) – approved for it in France
- Bisoprolol (Detensiel, Bisoprolol Eg, Bisoprolol Teva) – approved for it in France
- Bivalirudin (bivalirudin) – approved for it in the US
- Captopril (captopril, Captopril Viatris, Captopril Eg) – approved for it in the US and France
- Celiprolol (Celectol) – approved for it in France
- Dalteparin (Fragmin) – approved for it in the US
- Diltiazem (Tiazac Extended Release, Tildiem, Bi Tildiem L.p.) – approved for it in the US and France
- Ezetimibe (Ezetrol, Ezetimibe Zydus) – approved for it in France
- Ezetimibe and simvastatin (Vytorin, Inegy, Ezetimibe/Simvastatine Biogaran) – approved for it in the US and France
- Felodipine (Flodil L.p., Felodipine Sandoz L.p.) – approved for it in France
- Fluindione (Previscan) – approved for it in France
- Fluvastatin (Fluvastatin Sodium Er, Lescol L.p.) – approved for it in the US and France
- Gemfibrozil – approved for it in the US
- Glyceryl trinitrate (Nitrolingual, Nitriderm Tts, Nitrostat) – approved for it in the US, Switzerland, and France
- Icosapent ethyl (Vascepa) – approved for it in the US
- Isosorbide dinitrate (Isoket, Isosorbide Dinitrate) – approved for it in the US and Switzerland
- Heparin (Heparine Calcique Panpharma, Heparine Sodique Panpharma, Calciparine Sous Cutanee) – approved for it in France
- Isosorbide mononitrate (isosorbide mononitrate) – approved for it in the US
- Lisinopril (Qbrelis, Zestril, Lisinopril Eg) – approved for it in the US and France
- Lovastatin – approved for it in the US
- Metoprolol (Toprol Xl, Lopressor, Seloken) – approved for it in the US and France
- Molsidomine (Corvaton, Corvasal, Molsidomine Biogaran) – approved for it in Switzerland and France
- Nadolol (Nadolol, Corgard) – approved for it in the US and France
- Niacin – approved for it in the US
- Nicardipine (Nicardipine Hydrochloride) – approved for it in the US
- Nicorandil (Nicorandil Rivopharm, Nicorandil Zentiva) – approved for it in Switzerland and France
- Nifedipine (Procardia XL, Nifedipine Arrow L.p., Nifedipine Viatris L.p.) – approved for it in the US and France
- Perindopril (Perindopril Biogaran, Perindopril Erbumine, Perindopril Arrow) – approved for it in the US and France
- Nadroparin (Fraxiparine) – approved for it in France
- Perindopril and amlodipine (Perindopril Amlo Spirig HC, Perindopril-Amlodipin-Mepha Teva) – approved for it in Switzerland
- Pindolol (Visken Quinze) – approved for it in France
- Pravastatin (Pravastatin sodium, Pravastatine Eg) – approved for it in the US and France
- Propranolol (Propranolol Teva, Propranolol Eg) – approved for it in France
- Ramipril (Ramipril, Triatec, Ramipril Sandoz) – approved for it in the US and France
- Rosuvastatin and ezetimibe (Zenon, Quiloga) – approved for it in Switzerland and France
- Simvastatin (Zocor) – approved for it in the US
- Ticlopidine (Ticlopidine Eg) – approved for it in France
- Timolol (Timolol Maleate, Timacor) – approved for it in the US and France
- Tirofiban (Aggrastat, Agrastat, Tirofiban Medac) – approved for it in the US and France
- Trandolapril (Trandolapril, Odrik, Trandolapril Biogaran) – approved for it in the US and France
- Trimetazidine (Vastarel) – approved for it in France
- Verapamil (Isoptine L.p., Verapamil Eg L.p.) – approved for it in France
- Warfarin (Warfarin Sodium) – approved for it in the US
- Zofenopril (Zofenil) – approved for it in France
Being tested in people
26 open trials in Austria, 1024 worldwide. See the trials
- 1-month DAPT (Phase 3)
- 12-month DAPT (Standard of care) (Phase 3)
- Acetyl Salicylic Acid (ASA) (Phase 3)
- acetylsalicylic acid (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Dichloroacetate (DCA) (only single reports in people)
- Hyperthermia (only single reports in people)
- Ketogenic diet (only single reports in people)
- Mistletoe extract (only single reports in people)
- Ivermectin (animal studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
26 open trials in Austria, and 5 opening soon or by invitation
Prospective Cohort Study of Patients Undergoing Coronary Angiography in Vorarlberg, Austria
NCT07932327 · ClinicalTrials.gov
- Feldkirch – LKH Feldkirch
Age 18 and over
Contact the trial teamTests a sirolimus-releasing stent in people with coronary artery disease
NCT06779630 · ClinicalTrials.gov
- Graz – Klinische Abteilung für Kardiologie, Medizinische Universität Graz
- Vienna – Universitätsklinik für Innere Medizin II, Klinische Abteilung für Kardiologie, Medizinische Universität Wien
Age 18 and over
Contact the trial teamTracks safety and effectiveness of Medtronic products on the market
NCT01524276 · ClinicalTrials.gov
- Innsbruck – hospital not given
- Linz – hospital not given
No age limit given in the registry
Contact the trial teamCompares two heart artery procedures in people with weak heart pumping
NCT05427370 · ClinicalTrials.gov
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamRegistry tracking safety of Abbott heart and vessel devices in patients
NCT04573660 · ClinicalTrials.gov
- Graz – Universitätsklinik Graz
Age 18 and over
Contact the trial teamBlood Cell Gene Changes and Heart Damage After a Severe Heart Attack
NCT07615023 · ClinicalTrials.gov
- Innsbruck – Medical University of Innsbruck
Ages 18 to 75
Contact the trial teamTesting CRP apheresis to reduce heart damage after a heart attack
NCT04939805 · ClinicalTrials.gov
- Graz – University Clinic for Cardiology and Nephrology, Medical University of Graz
- Innsbruck – University Clinic of Internal Medicine III, Cardiology and Angiology. University Clinic of Internal Medicine IV, Nephrology and Hypertensiology. University Clinic of Radiology.
- Salzburg – University Clinic of Internal Medicine II, Paracelsus Medical University Salzburg
Ages 18 to 85
Contact the trial teamChecking heart arteries before valve replacement with a new scan
NCT07107568 · ClinicalTrials.gov
- Innsbruck – Medical University of Innsbruck
- Wels – Department of Internal Medicine II, Cardiology and Intensive Care Medicine, Klinikum Wels-Grieskirchen
Age 18 and over
Contact the trial teamTesting a heart risk score made for women aged 40 to 65 in Austria
NCT07849127 · ClinicalTrials.gov
- Klagenfurt – Anna Rab
Ages 40 to 65
Contact the trial teamTests clazakizumab in adults with kidney failure on dialysis
NCT05485961 · ClinicalTrials.gov
- Vienna – Wiener Gesundheitsverbund - Klinik Hietzing
Age 18 and over
Contact the trial teamMRI Scans to Study Heart Tissue After Heart Procedures
NCT07133984 · ClinicalTrials.gov
- Vienna – MU Vienna Austria
Age 18 and over
Contact the trial teamStudying inflammation linked to clonal hematopoiesis in healthy people and people with related diseases
NCT07780552 · ClinicalTrials.gov
- Innsbruck – Medical University Innsbruck
Age 18 and over
Contact the trial teamLandiolol given early to people having a heart attack with ST elevation
2025-523676-23-00 · EU Clinical Trials Register
- Vienna – Klinik Landstrasse
Age 18 and over
Contact the trial teamComparing One Versus Several Artery Grafts in Bypass Heart Surgery
NCT03217006 · ClinicalTrials.gov
- Innsbruck – Innsbruck (Medical University) Austria
- Vienna – Krankenhaus Nord Vienna North Hospital
- Vienna – MU Vienna Austria
Ages 18 to 70
Contact the trial teamAdding bempedoic acid to rosuvastatin and ezetimibe before planned artery procedures
2026-525917-29-00 · EU Clinical Trials Register
- Feldkirch – VIVIT
- Graz – Medical University of Graz
Age 18 and over
Contact the trial teamTests resilience training in heart patients during inpatient rehabilitation
NCT06332859 · ClinicalTrials.gov
- Bad Tatzmannsdorf – Rehabilitationszentrum Bad Tatzmannsdorf
Age 18 and over
Contact the trial teamTests artificial intelligence on blood cell data to predict heart attack
NCT06384846 · ClinicalTrials.gov
- Graz – Landeskrankenhaus Universitatsklinikum Graz
Age 18 and over
Contact the trial teamUsing Impella 5.5 pump data to track outcomes in cardiogenic shock
NCT07619144 · ClinicalTrials.gov
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamComparing two Impella CP pump settings during high-risk heart artery opening procedures
NCT07588399 · ClinicalTrials.gov
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamTests whether a defibrillator device is needed after a heart attack
NCT05665608 · ClinicalTrials.gov
- Feldkirch – Landeskrankenhaus Feldkirch
- Graz – LKH - Universitätsklinikum Graz
- Innsbruck – Tirol Kliniken - Universitätsklinik Innsbruck
- and 6 more sites
Age 18 and over
Contact the trial teamCompares two bypass surgery methods in women with coronary artery disease
NCT04124120 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Innsbruck Medical University
- Linz – Kepler University Hospital
- and 2 more sites
Age 18 and over
Contact the trial teamTests an early hospital discharge plan after a heart attack
NCT06744322 · ClinicalTrials.gov
- Feldkirch – Academic Teaching Hospital Feldkirch
- Graz – Medical University of Graz
- Innsbruck – Medical University of Innsbruck
- and 4 more sites
Age 18 and over
Contact the trial teamZiltivekimab Compared With Placebo for Heart Artery Plaque After a Heart Attack
NCT07301034 · ClinicalTrials.gov
- Vienna – Medizinische Universität Wien
Age 18 and over
Contact the trial teamDrug-coated balloons for opening blocked heart arteries during a heart attack
NCT07436429 · ClinicalTrials.gov
- Vienna – Universitätsklinikum AKH Wien
Age 18 and over
Contact the trial teamTicagrelor Plus Aspirin Versus Aspirin Alone After Heart Bypass Surgery
NCT05997693 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Linz – Johannes Kepler University
- and 1 more site
Age 18 and over
Contact the trial teamAnxiety and PTSD symptoms after a heart attack over time
NCT04130269 · ClinicalTrials.gov
- Graz – Medical University of Graz
Ages 19 to 90
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting Wearable Devices for Recovery After Intensive Care
NCT07035106 · ClinicalTrials.gov
- Vienna – Ludwig Boltzmann Institute Digital Health and Patient Safety
Ages 18 to 65
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies a dissolving heart stent in people with coronary artery disease
NCT06074549 · ClinicalTrials.gov
- Pölten – University hospital St. Pölten
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests pressure-wire guided stenting in people with coronary artery disease
NCT04451044 · ClinicalTrials.gov
- Feldkirch – Akademisches Lehrkrankenhaus Feldkirch
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamCompares two stenting approaches in heart attack patients with multivessel coronary disease
NCT05786131 · ClinicalTrials.gov
- Graz – LKH Univ. Klinikum Graz, Clinical Department of Cardiology
- Innsbruck – Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III
- Vienna – Klinik Ottakring, 3. medizinische Abteilung
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamComparing two ways of removing the left chest artery for heart bypass
NCT05931783 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medical University of Innsbruck
- Vienna – Medical University of Vienna
Ages 18 to 80
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Beyond Coronary Stenosis: Coronary Computed Tomography Angiography and the New Approach to the Coronary Atheroma Assessment.J Clin Med · 2026-11-02
- Regional Validation of Coronary Heart Disease Risk Factors in Psoriasis: A Multicenter Study in Southern China.J Clin Med · 2026-10-28
- In peopleAngiopoietin-like 4 (ANGPTL4) Protein and Its Relation to Lipids Challenges the Prognostic Performance of B-Type Natriuretic Peptide (BNP) Transcontinentally in Patients with Suspected Coronary Chest Pain, Suggesting Their Combined Use in Risk Prediction.Int J Mol Sci · 2026-11-06
- ReviewFocused Update on Randomized Trials in Acute Coronary Syndromes: A Scoping Review.J Clin Med · 2026-11-07
- ReviewCoronary Collateral Circulation in Coronary Syndromes: Echocardiographic Insights and Future Perspectives.Diagnostics (Basel) · 2026-11-09
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichischer Herzverband
Nationwide association for people with heart disease: guides, information on heart conditions, self-help groups and membership; regional branches.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- European Heart Network
Alliance of national heart foundations and associations (some representing patients); EU-level prevention policy and patient interest advocacy. Mixed, not purely patient-led.
- Global Heart Hub
Global umbrella of heart patient organisations; runs a Heart Failure Patient Network, awareness campaigns, advocacy and patient resources.
- World Heart Federation
Global cardiovascular federation (mixed: heart foundations, medical societies and advocacy groups, not purely patient-led); campaigns, policy and World Heart Day.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.